Hypoxia and macrophages promote glioblastoma invasion by the CCL4-CCR5 axis

Ying Wang1, Tao Liu2, Ning Yang2

  • 1Department of Rehabilitation, Qilu Children's Hospital of Shandong University, Jinan, Shandong, P.R. China.

Oncology Reports
|October 18, 2016
PubMed

Insights

Hypoxia and macrophages promote glioblastoma invasion via the CCL4-CCR5 axis. Hypoxia enhances this interaction by upregulating both CCL4 and CCR5, suggesting hypoxia as a potential target for glioblastoma immune therapies.

Area of Science:

  • Neuro-oncology
  • Immunology
  • Cancer biology

Background:

  • Glioblastoma (GBM) is a highly malignant brain tumor known for its invasive nature.
  • Macrophage infiltration is linked to GBM invasion, but the underlying mechanisms are not fully understood.
  • The tumor microenvironment in GBM is often characterized by hypoxia, influencing both tumor and immune cells.

Purpose of the Study:

  • To investigate the effects of hypoxia and macrophages on glioblastoma cell invasion.
  • To elucidate the potential mechanisms involved in hypoxia- and macrophage-mediated GBM invasion.

Main Methods:

  • Analysis of glioblastoma cell invasion assays.
  • Assessment of matrix metalloproteinase (MMP)-9 expression.
  • Evaluation of macrophage supernatant effects on glioblastoma cells.
  • Measurement of CCR5 expression in glioblastoma cells.
  • Analysis of CCL4 secretion by macrophages under varying oxygen conditions.
  • Investigation of interferon regulatory factor-8 (IRF-8) involvement.

Main Results:

  • Both hypoxia and macrophage supernatant significantly promoted glioblastoma cell invasion and MMP-9 expression.
  • Hypoxia upregulated CCR5 expression in glioblastoma cells, enhancing their invasive activity.
  • Hypoxic macrophages secreted more CCL4 than normoxic macrophages, increasing the pro-invasion effect.
  • Interferon regulatory factor-8 (IRF-8) may play a role in hypoxia-induced CCL4 expression in macrophages.

Conclusions:

  • Macrophages promote glioblastoma invasion through a CCL4-CCR5 signaling axis.
  • Hypoxia exacerbates glioblastoma invasion by upregulating both CCL4 and CCR5 expression.
  • Targeting hypoxia presents a potential strategy for developing novel immune therapies for glioblastoma.